Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dengue Virus | 6 | 2019 | 910 | 1.23 | Why? |
| Viral Plaque Assay | 1 | 2018 | 381 | 0.65 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.59 | Why? |
| Dengue | 5 | 2019 | 1565 | 0.56 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.51 | Why? |
| Population Density | 1 | 2017 | 694 | 0.45 | Why? |
| Severe Dengue | 2 | 2018 | 135 | 0.42 | Why? |
| Models, Theoretical | 6 | 2021 | 6659 | 0.41 | Why? |
| Population Surveillance | 2 | 2021 | 4967 | 0.36 | Why? |
| Infectious Disease Incubation Period | 3 | 2013 | 1033 | 0.30 | Why? |
| Chikungunya virus | 2 | 2019 | 339 | 0.29 | Why? |
| Neutralization Tests | 1 | 2018 | 6698 | 0.28 | Why? |
| Natural History | 1 | 2021 | 40 | 0.23 | Why? |
| Health Policy | 2 | 2021 | 6242 | 0.23 | Why? |
| Antibody-Dependent Enhancement | 1 | 2005 | 413 | 0.23 | Why? |
| Immune Sera | 1 | 2005 | 884 | 0.22 | Why? |
| Thailand | 4 | 2019 | 1155 | 0.21 | Why? |
| Antibodies, Viral | 5 | 2020 | 51949 | 0.20 | Why? |
| Leisure Activities | 1 | 2021 | 221 | 0.19 | Why? |
| Penicillin G Benzathine | 1 | 2018 | 14 | 0.19 | Why? |
| Immunoglobulin Isotypes | 1 | 2020 | 308 | 0.18 | Why? |
| Ebola Vaccines | 1 | 2019 | 126 | 0.18 | Why? |
| Epidemiologic Research Design | 1 | 2020 | 166 | 0.18 | Why? |
| Measles | 1 | 2005 | 608 | 0.18 | Why? |
| Arbovirus Infections | 1 | 2019 | 104 | 0.17 | Why? |
| Zika Virus | 3 | 2019 | 1924 | 0.17 | Why? |
| Mosquito Vectors | 2 | 2019 | 351 | 0.17 | Why? |
| Cluster Analysis | 3 | 2017 | 3001 | 0.16 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.15 | Why? |
| Respiratory Tract Infections | 3 | 2018 | 6817 | 0.15 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.15 | Why? |
| Endemic Diseases | 1 | 2019 | 480 | 0.14 | Why? |
| Chikungunya Fever | 1 | 2019 | 345 | 0.14 | Why? |
| Influenza, Human | 2 | 2017 | 10779 | 0.13 | Why? |
| Harm Reduction | 1 | 2018 | 392 | 0.13 | Why? |
| Substance Abuse, Intravenous | 1 | 2018 | 411 | 0.13 | Why? |
| Cell Phone | 1 | 2020 | 750 | 0.12 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.12 | Why? |
| Basic Reproduction Number | 2 | 2021 | 2676 | 0.12 | Why? |
| Patient Participation | 1 | 2019 | 829 | 0.12 | Why? |
| Antibodies, Neutralizing | 1 | 2018 | 25288 | 0.11 | Why? |
| Disease Transmission, Infectious | 4 | 2021 | 9044 | 0.11 | Why? |
| Disease Outbreaks | 5 | 2020 | 27595 | 0.11 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.11 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.10 | Why? |
| Humans | 34 | 2021 | 930598 | 0.09 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.09 | Why? |
| Disease Susceptibility | 2 | 2021 | 4002 | 0.09 | Why? |
| Public Health Surveillance | 2 | 2019 | 3129 | 0.09 | Why? |
| Databases, Factual | 2 | 2020 | 6248 | 0.09 | Why? |
| Child | 10 | 2021 | 70012 | 0.09 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2019 | 1475 | 0.09 | Why? |
| Schools | 2 | 2021 | 4187 | 0.09 | Why? |
| Military Personnel | 1 | 2018 | 1097 | 0.09 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Dengue Vaccines | 2 | 2019 | 123 | 0.08 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.08 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.08 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.08 | Why? |
| Periodicity | 1 | 2005 | 34 | 0.08 | Why? |
| Serotyping | 1 | 2005 | 154 | 0.08 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| Insect Vectors | 2 | 2018 | 227 | 0.07 | Why? |
| Linear Models | 2 | 2016 | 1914 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2019 | 1920 | 0.07 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.07 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.07 | Why? |
| Mobile Applications | 1 | 2020 | 3032 | 0.07 | Why? |
| Cameroon | 1 | 2005 | 464 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Aging | 1 | 2020 | 3581 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.07 | Why? |
| Phylogeny | 3 | 2019 | 13341 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Vietnam | 2 | 2019 | 1665 | 0.06 | Why? |
| Decision Support Techniques | 1 | 2010 | 903 | 0.06 | Why? |
| Measles Vaccine | 1 | 2005 | 301 | 0.06 | Why? |
| History, 21st Century | 2 | 2020 | 1849 | 0.06 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.06 | Why? |
| Population Dynamics | 1 | 2005 | 378 | 0.06 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.05 | Why? |
| History, 18th Century | 1 | 2020 | 192 | 0.05 | Why? |
| Cross Infection | 2 | 2013 | 8675 | 0.05 | Why? |
| Guinea | 1 | 2019 | 228 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.05 | Why? |
| Disease Reservoirs | 2 | 2020 | 1672 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.05 | Why? |
| Haiti | 1 | 2019 | 175 | 0.05 | Why? |
| Coinfection | 1 | 2019 | 6820 | 0.05 | Why? |
| History, 19th Century | 1 | 2020 | 384 | 0.05 | Why? |
| Infant | 4 | 2020 | 30274 | 0.05 | Why? |
| Masks | 1 | 2021 | 8528 | 0.05 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2018 | 191 | 0.04 | Why? |
| Behavior | 1 | 2020 | 252 | 0.04 | Why? |
| Community-Acquired Infections | 1 | 2010 | 2328 | 0.04 | Why? |
| Senegal | 1 | 2018 | 283 | 0.04 | Why? |
| Factor Analysis, Statistical | 1 | 2019 | 538 | 0.04 | Why? |
| Haplorhini | 1 | 2018 | 307 | 0.04 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.04 | Why? |
| Viruses | 1 | 2010 | 2238 | 0.04 | Why? |
| United States | 2 | 2021 | 46150 | 0.04 | Why? |
| Species Specificity | 1 | 2020 | 1356 | 0.04 | Why? |
| Culicidae | 1 | 2018 | 239 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Animals | 6 | 2020 | 78931 | 0.04 | Why? |
| Seasons | 2 | 2019 | 4071 | 0.04 | Why? |
| Adult | 11 | 2021 | 244371 | 0.04 | Why? |
| Aedes | 1 | 2019 | 380 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2019 | 21571 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.04 | Why? |
| Models, Biological | 2 | 2018 | 4907 | 0.04 | Why? |
| Forecasting | 2 | 2020 | 4492 | 0.03 | Why? |
| Serogroup | 1 | 2016 | 510 | 0.03 | Why? |
| History, 20th Century | 1 | 2020 | 1282 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Male | 11 | 2021 | 367725 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Saudi Arabia | 2 | 2016 | 4423 | 0.03 | Why? |
| Female | 11 | 2021 | 380317 | 0.03 | Why? |
| Switzerland | 1 | 2021 | 2738 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2007 | 2984 | 0.03 | Why? |
| Virus Diseases | 1 | 2010 | 3779 | 0.03 | Why? |
| Geography | 1 | 2019 | 1801 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Climate | 1 | 2016 | 557 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.02 | Why? |
| Africa | 1 | 2018 | 2986 | 0.02 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Qualitative Research | 1 | 2019 | 4337 | 0.02 | Why? |
| Probability | 1 | 2010 | 923 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Base Sequence | 1 | 2013 | 3581 | 0.02 | Why? |
| Symptom Assessment | 1 | 2019 | 4967 | 0.02 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.02 | Why? |
| Virus Replication | 1 | 2005 | 14331 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Coronavirus | 1 | 2013 | 18339 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Vaccination | 2 | 2019 | 19050 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.02 | Why? |
| DNA, Viral | 1 | 2013 | 2521 | 0.02 | Why? |
| Genetic Variation | 1 | 2016 | 3919 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Zoonoses | 1 | 2016 | 3034 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Software | 1 | 2010 | 2501 | 0.01 | Why? |
| Genome, Viral | 1 | 2019 | 13157 | 0.01 | Why? |
| Renal Dialysis | 1 | 2013 | 4358 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Length of Stay | 1 | 2010 | 11042 | 0.01 | Why? |
| Prospective Studies | 1 | 2016 | 43301 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 9706 | 0.01 | Why? |
| Time Factors | 1 | 2010 | 31397 | 0.01 | Why? |
| Intensive Care Units | 1 | 2013 | 29594 | 0.00 | Why? |
Cummings's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(172)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_